EU Approves Subcutaneous Pembrolizumab in All Approved Indications
Refining Management of Immune-Checkpoint Inhibitor Toxicities in Melanoma: An article by Cancer Network Staff discusses the refining process of managing immune-checkpoint inhibitor toxicities in Melanoma. Read more
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma: The FDA paints a ray of hope in treating recurrent high-grade glioma by fast-tracking the SRN-101. Read more from an insightful article authored by Cancer Network Staff. Read more
Novel Small Molecule Shows Early Activity in Pretreated Multiple Myeloma: Saad Z. Usmani, MD, MBA, FACP documents the early impact of a novel molecule in pretreated multiple myeloma in his article. Read more
Comparing Quality of Life Outcomes with Protons vs Photons in OPSCC: Roman Fabbricatore draws a comparison between life outcomes using protons and photons in OPSCC through his article. Read more
3 Things You Should Know About PSMA-Directed Imaging and Radioligand Therapy in Prostate Cancer: Oncology Staff shares critical insight into PSMA-Directed Imaging and Radioligand Therapy in Prostate cancer in a recent article. Read more
